home / stock / avtr / avtr news


AVTR News and Press, Avantor Inc. From 04/28/22

Stock Information

Company Name: Avantor Inc.
Stock Symbol: AVTR
Market: NYSE
Website: avantorsciences.com

Menu

AVTR AVTR Quote AVTR Short AVTR News AVTR Articles AVTR Message Board
Get AVTR Alerts

News, Short Squeeze, Breakout and More Instantly...

AVTR - Avantor Non-GAAP EPS of $0.38 beats by $0.02, revenue of $1.95B beats by $20M

Avantor press release (NYSE:AVTR): Q1 Non-GAAP EPS of $0.38 beats by $0.02. Revenue of $1.95B (+8.9% Y/Y) beats by $20M. Shares +0.5%. For further details see: Avantor Non-GAAP EPS of $0.38 beats by $0.02, revenue of $1.95B beats by $20M

AVTR - Avantor® Reports First Quarter 2022 Results

Avantor® Reports First Quarter 2022 Results PR Newswire Net sales of $1.95 billion , increase of 9.2%; organic net sales growth of 5.1% Net income of $190.4 million ; Adjusted EBITDA of $423.1 million Diluted GAAP EPS of $0.28 ; adjusted EP...

AVTR - ClearBridge Investments Global Growth Strategy Q1 2022 Commentary

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A sharp spike in bond yields pressured growth stocks and ...

AVTR - Bank of America is cautious on life sciences companies ahead of earnings

As Danaher (DHR) is set to kick off the earnings season of the makers of Life Sciences & Diagnostic Tools on Thursday, Bank of America analysts led by Derik de Bruin issued cautious views on the subsector, citing macro and geopolitical headwinds. The earnings season for the group com...

AVTR - Avantor® to Report First Quarter 2022 Results and Host Earnings Call on April 29, 2022

Avantor® to Report First Quarter 2022 Results and Host Earnings Call on April 29, 2022 PR Newswire RADNOR, Pa. , April 6, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customer...

AVTR - Avantor cut to Neutral at Citi on less compelling near-term outlook

Life sciences company Avantor (AVTR -3.7%) is trading lower after Citi downgraded the stock to Neutral from Buy, citing a limited opportunity for near-term topline growth and margin expansion, particularly in the second half of this year. The price target trimmed by more than a fifth to $38 p...

AVTR - Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2021 Update

Halvorsen's 13F portfolio value decreased from $36.04B to $34.49B this quarter. The number of positions increased from 96 to 107. Viking Global added Twilio, Workday, and Aon plc while dropping Fidelity National Information Services and Snowflake. The top three positions are Ginkg...

AVTR - Avantor® to Participate in KeyBanc Life Sciences and Medtech Investor Forum

Avantor® to Participate in KeyBanc Life Sciences and Medtech Investor Forum PR Newswire RADNOR, Pa. , March 8, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life ...

AVTR - Tracking Dan Loeb's Third Point Portfolio - Q4 2021 Update

Dan Loeb's 13F portfolio value decreased from $18.32B to $14.33B this quarter. The number of positions decreased from 113 to 92. Third Point increased Amazon, RH, and Catalent while decreasing Upstart Holdings and Walt Disney during the quarter. The top three positions are at ~23%...

AVTR - Avantor: Recurrent Revenue And M&A Could Push The Stock Price Up

Avantor sells products and services to the biopharma, healthcare, education, government, and advanced technologies & applied materials industries. In my view, what really matters is that Avantor expects $1 billion FCF, positive adjusted EPS close to $1.4-$1.5, and an EBITDA margin...

Previous 10 Next 10